Immunic (IMUX) soars on news of IMU-838 demonstrating activity against SARS-CoV-2 Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Immunic (IMUX) up 46% after reporting that its lead asset, IMU-838, has demonstrated preclinical activity against severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2.
- Mallinckrodt (MNK) up 7% after announcing that the FDA has accepted for review the company's new drug application for terlipressin, an investigational agent being evaluated for the treatment of hepatorenal syndrome type 1
- Expedia (EXPE) up 6%
after Wall Street Journal reports the company is nearing a deal to sell a stake in itself to private equity firms Silver Lake and Apollo (APO)
UP AFTER EARNINGS -
- AT&T (T) up 3%
- Delta Air Lines (DAL) up 2%
- Kimberly-Clark (KMB) up 1%
- Quest Diagnostics (DGX) up 2%
- Snap (SNAP) up 20%
- Teradyne (TER) up 6%
- Chipotle (CMG) up 7%
DOWN AFTER EARNINGS -
- Biogen (BIIB) down 6%
- Netflix (NFLX) down 2%
- Interactive Brokers (IBKR) down 9%
ALSO LOWER -
- iRobot (IRBT) down 2% after JPMorgan analyst Mark Strouse downgraded shares to Underweight from Neutral with a price target of $41, down from $43
Symbols:
IMUX MNK EXPE T DAL KMB DGX TER CMG - $781.00 /
-29.69 (-3.66%)
BIIB NFLX IBKR IRBT Keywords: Fly Intel, Wall Street, Top Stories, Stocks